|
Market Cap | 366.67M | EPS (ttm) | -1.26 |
P/E | - | EPS this Y | 40.80% |
Forward P/E | - | EPS next Y | 13.20% |
PEG | - | EPS past 5Y | -3.90% |
P/S | 101.85 | EPS next 5Y | - |
P/B | 1.74 | EPS Q/Q | 19.29% |
Dividend | - | Sales Q/Q | - |
Insider Own | 27.90% | Inst Own | 33.33% |
Insider Trans | 0.40% | Inst Trans | 0.28% |
Short Float | 3.63% | Earnings | Mar 18/a |
Analyst Recom | 1.33 | Target Price | 4.00 |
Avg Volume | 2.10M | 52W Range | 0.68 - 2.97 |
|
|
|
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lupher, Jr. Mark L. | Director | Feb 07 '24 | Buy | 1.35 | 130,000 | 175,500 | 130,000 | Feb 09 05:50 PM | Scopa James Paul | Director | Feb 07 '24 | Buy | 1.35 | 100,000 | 135,000 | 100,000 | Feb 09 05:51 PM | Seyedkazemi Setareh | Chief Development Officer | Sep 15 '23 | Sale | 1.52 | 6,201 | 9,429 | 47,674 | Sep 18 06:54 PM | Rubinstein Linda M | Chief Financial Officer | Jun 07 '23 | Buy | 1.45 | 100,000 | 145,490 | 100,000 | Jun 09 04:26 PM |
|
|
|
|
Market Cap | 2.32B | EPS (ttm) | -0.64 |
P/E | - | EPS this Y | -130.27% |
Forward P/E | - | EPS next Y | -17.64% |
PEG | - | EPS past 5Y | 24.56% |
P/S | 39.48 | EPS next 5Y | - |
P/B | 10.81 | EPS Q/Q | 135.59% |
Dividend | - | Sales Q/Q | 1011.42% |
Insider Own | 28.22% | Inst Own | 68.33% |
Insider Trans | -16.25% | Inst Trans | 37.62% |
Short Float | 9.41% | Earnings | Mar 18/a |
Analyst Recom | 1.00 | Target Price | 37.00 |
Avg Volume | 1.06M | 52W Range | 6.39 - 39.27 |
|
|
|
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rickey James Paul | See Remarks | Jan 26 '24 | Option Exercise | 8.30 | 117,764 | 977,844 | 73,764 | Jan 29 07:04 PM | Rickey James Paul | See Remarks | Jan 26 '24 | Sale | 23.32 | 117,764 | 2,745,830 | 0 | Jan 29 07:04 PM | Rickey James Paul | See Remarks | Jan 25 '24 | Option Exercise | 6.51 | 236 | 1,536 | 236 | Jan 29 07:04 PM | Rickey James Paul | See Remarks | Jan 25 '24 | Sale | 22.00 | 236 | 5,192 | 0 | Jan 29 07:04 PM | GOLD MITCHELL | Executive Chairman and CEO | Dec 28 '23 | Option Exercise | 12.74 | 74,441 | 948,378 | 2,675,421 | Dec 29 07:32 PM |
|
|
|
|
Market Cap | 137.46M | EPS (ttm) | -0.44 |
P/E | - | EPS this Y | 5.30% |
Forward P/E | - | EPS next Y | 54.40% |
PEG | - | EPS past 5Y | 62.58% |
P/S | 3.06 | EPS next 5Y | - |
P/B | 187.29 | EPS Q/Q | 38.77% |
Dividend | - | Sales Q/Q | 44.90% |
Insider Own | 10.86% | Inst Own | 86.87% |
Insider Trans | 50.79% | Inst Trans | 0.70% |
Short Float | 1.95% | Earnings | Mar 18/a |
Analyst Recom | 1.50 | Target Price | 6.00 |
Avg Volume | 363.70K | 52W Range | 1.34 - 6.25 |
|
|
|
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ginocchio Paul | CHIEF FINANCIAL OFFICER | Nov 22 '23 | Buy | 4.85 | 10,000 | 48,500 | 128,000 | Nov 27 07:00 AM | Redmile Group, LLC | Director | Nov 20 '23 | Buy | 4.00 | 750,000 | 3,000,000 | 16,404,017 | Nov 22 04:15 PM | Redmile Group, LLC | Director | Nov 20 '23 | Buy | 4.00 | 750,000 | 3,000,000 | 9,446,146 | Nov 22 04:15 PM | Traylor Margie L. | Director | Jun 14 '23 | Buy | 4.51 | 26,530 | 119,649 | 47,331 | Jun 16 05:50 PM | Traylor Margie L. | Director | May 15 '23 | Option Exercise | 2.20 | 10,182 | 22,400 | 20,801 | May 17 07:00 PM |
|
|
| |
|
Market Cap | 184.52M | EPS (ttm) | -0.99 |
P/E | - | EPS this Y | -172.22% |
Forward P/E | - | EPS next Y | -96.15% |
PEG | - | EPS past 5Y | -83.26% |
P/S | 5.39 | EPS next 5Y | - |
P/B | 2.23 | EPS Q/Q | 87.18% |
Dividend | - | Sales Q/Q | 32.61% |
Insider Own | 0.48% | Inst Own | 43.88% |
Insider Trans | 0.00% | Inst Trans | -44.94% |
Short Float | 19.05% | Earnings | Mar 18/a |
Analyst Recom | 1.00 | Target Price | 6.07 |
Avg Volume | 9.71M | 52W Range | 1.12 - 5.27 |
|
|
|
Bit Digital, Inc. engages in the digital asset mining business and Ethereum staking activities. The company was founded in November 2015 and is headquartered in New York, NY. |
|
|
|
Market Cap | 130.96M | EPS (ttm) | -0.87 |
P/E | - | EPS this Y | 80.17% |
Forward P/E | 15.08 | EPS next Y | 227.08% |
PEG | - | EPS past 5Y | - |
P/S | 0.23 | EPS next 5Y | 17.00% |
P/B | 0.30 | EPS Q/Q | 75.36% |
Dividend | - | Sales Q/Q | 15.84% |
Insider Own | 7.05% | Inst Own | 70.27% |
Insider Trans | 0.00% | Inst Trans | -1.89% |
Short Float | 3.91% | Earnings | Mar 18/a |
Analyst Recom | 2.00 | Target Price | 17.08 |
Avg Volume | 364.14K | 52W Range | 4.13 - 13.17 |
|
|
|
Comtech Telecommunications Corp. engages in the provision of emergency systems and wireless and satellite communications. It operates through Satellite and Space Communications and Terrestrial and Wireless Networks segments. The Satellite and Space Communication segment offers satellite ground station technologies, services and system integration that facilitate the transmission of voice, video, and data over GEO, MEO, and LEO satellite constellations, including solid-state and traveling wave tube power amplifiers, modems, VSAT platforms and frequency converters. The Terrestrial and Wireless Networks segment provides SMS Text to 911 services, providing alternate paths for individuals who need to request assistance method to reach Public Safety Answering Points. The company was founded in 1967 and is headquartered in Melville, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Carpenter Wendi B. | Director | Jun 26 '23 | Buy | 9.60 | 1,000 | 9,600 | 4,506 | Jun 28 09:02 PM | Quinlan Mark R. | Director | Jun 21 '23 | Buy | 8.89 | 100,000 | 888,570 | 347,639 | Jun 23 04:55 PM | Carpenter Wendi B. | Director | Jun 15 '23 | Buy | 9.20 | 1,000 | 9,200 | 3,500 | Jun 15 06:04 PM | HEDDEN MARIA | Chief Operating Officer | Jun 14 '23 | Buy | 8.95 | 2,233 | 19,985 | 7,247 | Jun 15 04:06 PM | Walther Donald E. | Chief Legal Officer | Jun 14 '23 | Buy | 8.86 | 500 | 4,430 | 1,000 | Jun 14 04:10 PM |
|
|
| |
|
Market Cap | 5.38B | EPS (ttm) | 0.48 |
P/E | 37.89 | EPS this Y | 53.35% |
Forward P/E | 17.62 | EPS next Y | 37.31% |
PEG | 1.16 | EPS past 5Y | - |
P/S | 9.27 | EPS next 5Y | 32.70% |
P/B | 12.22 | EPS Q/Q | 39.20% |
Dividend | - | Sales Q/Q | 46.54% |
Insider Own | 74.79% | Inst Own | 20.51% |
Insider Trans | 0.00% | Inst Trans | 0.10% |
Short Float | 7.88% | Earnings | Mar 18/a |
Analyst Recom | 2.60 | Target Price | 19.75 |
Avg Volume | 894.00K | 52W Range | 9.04 - 24.22 |
|
|
|
DLocal Ltd. engages in the business of simplifying and redefining online payments experience. It focuses on processing payment transactions which enables merchants to get paid from customers and to make payments to customers in emerging markets. The company was founded by Andres Bzurovski Bay and Sergio Enrique Fogel Kaplan in 2016 and is headquartered in Montevideo, Uruguay. |
|
|
|
Market Cap | 67.50M | EPS (ttm) | -0.67 |
P/E | - | EPS this Y | -38.31% |
Forward P/E | - | EPS next Y | -14.72% |
PEG | - | EPS past 5Y | -7.37% |
P/S | - | EPS next 5Y | - |
P/B | 4.16 | EPS Q/Q | 13.36% |
Dividend | - | Sales Q/Q | - |
Insider Own | 18.44% | Inst Own | 25.89% |
Insider Trans | 0.28% | Inst Trans | -31.84% |
Short Float | 8.03% | Earnings | Mar 18/a |
Analyst Recom | 1.00 | Target Price | 9.25 |
Avg Volume | 738.68K | 52W Range | 1.05 - 5.85 |
|
|
|
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Grant Stuart M. | 10% Owner | Mar 08 '24 | Buy | 1.58 | 10,717 | 16,911 | 5,280,715 | Mar 11 08:11 AM | Rowe Michael M | Chief Executive Officer | Dec 04 '23 | Buy | 1.36 | 4,890 | 6,650 | 32,927 | Dec 05 04:54 PM | Strahlman Ellen R | Director | Sep 29 '23 | Buy | 1.68 | 4,820 | 8,098 | 75,113 | Oct 02 10:04 AM | Rowe Michael M | Chief Executive Officer | Sep 19 '23 | Buy | 1.66 | 1,400 | 2,324 | 28,037 | Sep 19 05:17 PM | Rowe Michael M | Chief Executive Officer | Sep 15 '23 | Buy | 1.75 | 1,137 | 1,990 | 26,637 | Sep 19 05:17 PM |
|
|
| |
|
Market Cap | 842.31M | EPS (ttm) | 1.18 |
P/E | 4.23 | EPS this Y | 20.83% |
Forward P/E | 2.90 | EPS next Y | 22.44% |
PEG | 2.42 | EPS past 5Y | - |
P/S | 0.48 | EPS next 5Y | 1.75% |
P/B | 0.46 | EPS Q/Q | -7.83% |
Dividend | 4.75% | Sales Q/Q | 1.76% |
Insider Own | 0.03% | Inst Own | 50.91% |
Insider Trans | 0.00% | Inst Trans | -0.25% |
Short Float | 0.87% | Earnings | Mar 18/a |
Analyst Recom | 1.00 | Target Price | 6.31 |
Avg Volume | 800.68K | 52W Range | 3.55 - 6.05 |
|
|
|
FinVolution Group is an online consumer finance platform in China connecting underserved individual borrowers with financial institutions. It developed technologies and accumulated in-depth experience in the core areas of credit risk assessment, fraud detection, big data, and artificial intelligence. The company's platform empowered by proprietary cutting-edge technologies, features an automated loan transaction process, which enables superior user experience. The company was founded by Shao Feng Gu, Hong Hui Hu, Tie Zeng Li, and Jun Zhang in June 2007 and is headquartered in Shanghai, China. |
|
|
|
Market Cap | 108.27M | EPS (ttm) | -1.40 |
P/E | - | EPS this Y | -33.56% |
Forward P/E | - | EPS next Y | 27.16% |
PEG | - | EPS past 5Y | -47.77% |
P/S | - | EPS next 5Y | - |
P/B | 2.38 | EPS Q/Q | -39.40% |
Dividend | - | Sales Q/Q | - |
Insider Own | 26.51% | Inst Own | 10.80% |
Insider Trans | -19.46% | Inst Trans | 0.91% |
Short Float | 0.85% | Earnings | Mar 18/a |
Analyst Recom | 1.00 | Target Price | 20.50 |
Avg Volume | 206.41K | 52W Range | 2.38 - 9.59 |
|
|
|
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kreis Leslie W. | 10% Owner | Feb 29 '24 | Sale | 4.87 | 19,703 | 95,954 | 60,256 | Feb 29 09:54 PM | Fletcher Aaron G.L. | 10% Owner | Feb 29 '24 | Sale | 4.87 | 19,703 | 95,954 | 60,256 | Feb 29 09:54 PM | Fletcher Aaron G.L. | 10% Owner | Feb 28 '24 | Sale | 4.85 | 74,297 | 360,340 | 62,088 | Feb 29 09:54 PM | Kreis Leslie W. | 10% Owner | Feb 28 '24 | Sale | 4.85 | 74,297 | 360,340 | 62,088 | Feb 29 09:54 PM | Kreis Leslie W. | 10% Owner | Feb 27 '24 | Sale | 4.40 | 50,000 | 220,000 | 68,997 | Feb 29 09:54 PM |
|
|
|
|
Market Cap | 556.20M | EPS (ttm) | 0.17 |
P/E | 72.92 | EPS this Y | 14.15% |
Forward P/E | 10.09 | EPS next Y | 12.66% |
PEG | 4.86 | EPS past 5Y | - |
P/S | 3.24 | EPS next 5Y | 15.00% |
P/B | 2.67 | EPS Q/Q | -471.43% |
Dividend | - | Sales Q/Q | -4.54% |
Insider Own | 3.24% | Inst Own | 78.13% |
Insider Trans | -5.66% | Inst Trans | 0.19% |
Short Float | 6.95% | Earnings | Mar 19/a |
Analyst Recom | 1.00 | Target Price | 17.50 |
Avg Volume | 355.71K | 52W Range | 8.73 - 13.98 |
|
|
|
Mitek Systems, Inc. engages in the development of mobile capture and digital identity verification solutions. The company was founded in 1986 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CARNECCHIA SCIPIO MAXIMUS | Chief Executive Officer | Dec 07 '23 | Sale | 10.86 | 56,113 | 609,387 | 500,795 | Dec 12 01:58 PM | Diamond Michael E | General Manager | Dec 07 '23 | Sale | 10.86 | 7,242 | 78,648 | 266,304 | Dec 12 01:56 PM | Briggs Christopher H | SVP Identity | Dec 07 '23 | Sale | 10.86 | 2,287 | 24,837 | 92,673 | Dec 12 01:51 PM | CARNECCHIA SCIPIO MAXIMUS | Chief Executive Officer | Dec 01 '23 | Sale | 11.07 | 12,370 | 136,936 | 556,908 | Dec 12 01:58 PM | Diamond Michael E | General Manager | Dec 01 '23 | Sale | 11.07 | 1,996 | 22,096 | 273,546 | Dec 12 01:56 PM |
|
|
|